|
1
|
Zhang X and Li X: Abnormal iron and lipid
metabolism mediated ferroptosis in kidney diseases and its
therapeutic potential. Metabolites. 12(58)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dixon SJ and Stockwell BR: The role of
iron and reactive oxygen species in cell death. Nat Chem Biol.
10:9–17. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tuo QZ, Lei P, Jackman KA, Li XL, Xiong H,
Li XL, Liuyang ZY, Roisman L, Zhang ST, Ayton S, et al:
Tau-mediated iron export prevents ferroptotic damage after ischemic
stroke. Mol Psychiatry. 22:1520–1530. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lu X, Rudemiller NP, Ren J, Wen Y, Yang B,
Griffiths R, Privratsky JR, Madan B, Virshup DM and Crowley SD:
Opposing actions of renal tubular- and myeloid-derived porcupine in
obstruction-induced kidney fibrosis. Kidney Int. 96:1308–1319.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Humphreys BD: Mechanisms of renal
fibrosis. Annu Rev Physiol. 80:309–326. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dolma S, Lessnick SL, Hahn WC and
Stockwell BR: Identification of genotype-selective antitumor agents
using synthetic lethal chemical screening in engineered human tumor
cells. Cancer Cell. 3:285–296. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol
Cell. 73:354–363.e3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee YS, Lee DH, Choudry HA, Bartlett DL
and Lee YJ: Ferroptosis-induced endoplasmic reticulum stress:
Cross-talk between ferroptosis and apoptosis. Mol Cancer Res.
16:1073–1076. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hirayama T, Miki A and Nagasawa H:
Organelle-specific analysis of labile Fe(ii) during ferroptosis by
using a cocktail of various colour organelle-targeted fluorescent
probes. Metallomics. 11:111–117. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lin X, Ping J, Wen Y and Wu Y: The
mechanism of ferroptosis and applications in tumor treatment. Front
Pharmacol. 11(1061)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285.
2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11(88)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yi J, Zhu J, Wu J, Thompson CB and Jiang
X: Oncogenic activation of PI3K-AKT-mTOR signaling suppresses
ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA.
117:31189–31197. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wen J, Chen H, Ren Z, Zhang P, Chen J and
Jiang S: Ultrasmall iron oxide nanoparticles induced ferroptosis
via beclin1/ATG5-dependent autophagy pathway. Nano Converg.
8(10)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Galaris D, Barbouti A and Pantopoulos K:
Iron homeostasis and oxidative stress: An intimate relationship.
Biochim Biophys Acta Mol Cell Res. 1866(118535)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang S, Luo J, Zhang Z, Dong D, Shen Y,
Fang Y, Hu L, Liu M, Dai C, Peng S, et al: Iron and magnetic: New
research direction of the ferroptosis-based cancer therapy. Am J
Cancer Res. 8:1933–1946. 2018.PubMed/NCBI
|
|
20
|
Dixon SJ, Winter GE, Musavi LS, Lee ED,
Snijder B, Rebsamen M, Superti-Furga G and Stockwell BR: Human
haploid cell genetics reveals roles for lipid metabolism genes in
nonapoptotic cell death. ACS Chem Biol. 10:1604–1609.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dai C, Chen X, Li J, Comish P, Kang R and
Tang D: Transcription factors in ferroptotic cell death. Cancer
Gene Ther. 27:645–656. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lewerenz J, Hewett SJ, Huang Y, Lambros M,
Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M,
et al: The cystine/glutamate antiporter system x(c)(-) in health
and disease: From molecular mechanisms to novel therapeutic
opportunities. Antioxid Redox Signal. 18:522–555. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bannai S: Exchange of cystine and
glutamate across plasma membrane of human fibroblasts. J Biol Chem.
261:2256–2263. 1986.PubMed/NCBI
|
|
24
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lang X, Green MD, Wang W, Yu J, Choi JE,
Jiang L, Liao P, Zhou J, Zhang Q, Dow A, et al: Radiotherapy and
immunotherapy promote tumoral lipid oxidation and ferroptosis via
synergistic repression of SLC7A11. Cancer Discov. 9:1673–1685.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sato H, Shiiya A, Kimata M, Maebara K,
Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T,
et al: Redox imbalance in cystine/glutamate transporter-deficient
mice. J Biol Chem. 280:37423–37429. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Badgley MA, Kremer DM, Maurer HC,
DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J,
Firl CEM, et al: Cysteine depletion induces pancreatic tumor
ferroptosis in mice. Science. 368:85–89. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chang LC, Chiang SK, Chen SE, Yu YL, Chou
RH and Chang WC: Heme oxygenase-1 mediates BAY 11-7085 induced
ferroptosis. Cancer Lett. 416:124–137. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gan B: Mitochondrial regulation of
ferroptosis. J Cell Biol. 220(e202105043)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kuhn H, Banthiya S and van Leyen K:
Mammalian lipoxygenases and their biological relevance. Biochim
Biophys Acta. 1851:308–330. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qureshi T, Sørensen C, Berghuis P, Jensen
V, Dobszay MB, Farkas T, Dalen KT, Guo C, Hassel B, Utheim TP, et
al: The glutamine transporter Slc38a1 regulates GABAergic
neurotransmission and synaptic plasticity. Cereb Cortex.
29:5166–5179. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang Y, Tai W, Lu N, Li T, Liu Y, Wu W, Li
Z, Pu L, Zhao X, Zhang T and Dong Z: lncRNA ZFAS1 promotes lung
fibroblast-to-myofibroblast transition and ferroptosis via
functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging
(Albany NY). 12:9085–9102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chen X, Yu C, Kang R and Tang D: Iron
metabolism in ferroptosis. Front Cell Dev Biol.
8(590226)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Doll S and Conrad M: Iron and ferroptosis:
A still ill-defined liaison. IUBMB Life. 69:423–434.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Alvarez SW, Sviderskiy VO, Terzi EM,
Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K
and Possemato R: NFS1 undergoes positive selection in lung tumours
and protects cells from ferroptosis. Nature. 551:639–643.
2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen PH, Wu J, Ding CC, Lin CC, Pan S,
Bossa N, Xu Y, Yang WH, Mathey-Prevot B and Chi JT: Kinome screen
of ferroptosis reveals a novel role of ATM in regulating iron
metabolism. Cell Death Differ. 27:1008–1022. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mazure NM: VDAC in cancer. Biochim Biophys
Acta Bioenerg. 1858:665–673. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:864–868.
2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
McBean GJ: The transsulfuration pathway: A
source of cysteine for glutathione in astrocytes. Amino Acids.
42:199–205. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sedeek M, Nasrallah R, Touyz RM and Hébert
RL: NADPH oxidases, reactive oxygen species, and the kidney: Friend
and foe. J Am Soc Nephrol. 24:1512–1518. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Guerrero-Hue M, García-Caballero C,
Palomino-Antolín A, Rubio-Navarro A, Vázquez-Carballo C, Herencia
C, Martín-Sanchez D, Farré-Alins V, Egea J, Cannata P, et al:
Curcumin reduces renal damage associated with rhabdomyolysis by
decreasing ferroptosis-mediated cell death. FASEB J. 33:8961–8975.
2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Linkermann A, Chen G, Dong G, Kunzendorf
U, Krautwald S and Dong Z: Regulated cell death in AKI. J Am Soc
Nephrol. 25:2689–2701. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Su H, Wan C, Song A, Qiu Y, Xiong W and
Zhang C: Oxidative stress and renal fibrosis: Mechanisms and
therapies. Adv Exp Med Biol. 1165:585–604. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li X, Zou Y, Xing J, Fu YY, Wang KY, Wan
PZ and Zhai XY: Pretreatment with roxadustat (FG-4592) attenuates
folic acid-induced kidney injury through antiferroptosis via
Akt/GSK-3 β/Nrf2 pathway. Oxid Med Cell Longev.
2020(6286984)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ide S, Kobayashi Y, Ide K, Strausser SA,
Abe K, Herbek S, O'Brien LL, Crowley SD, Barisoni L, Tata A, et al:
Ferroptotic stress promotes the accumulation of pro-inflammatory
proximal tubular cells in maladaptive renal repair. Elife.
10(e68603)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Feng X, Wang S, Sun Z, Dong H, Yu H, Huang
M and Gao X: Ferroptosis enhanced diabetic renal tubular injury via
HIF-1α/HO-1 pathway in db/db mice. Front Endocrinol (Lausanne).
12(626390)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Liu B, Deng Q, Zhang L and Zhu W:
Nobiletin alleviates ischemia/reperfusion injury in the kidney by
activating PI3K/AKT pathway. Mol Med Rep. 22:4655–4662.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Lo YH, Yang SF, Cheng CC, Hsu KC, Chen YS,
Chen YY, Wang CW, Guan SS and Wu CT: Nobiletin alleviates
ferroptosis-associated renal injury, inflammation, and fibrosis in
a unilateral ureteral obstruction mouse model. Biomedicines.
10(595)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yang L and Xia H: TRIM proteins in
inflammation: From expression to emerging regulatory mechanisms.
Inflammation. 44:811–820. 2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Bilgin S, Kurtkulagi O, Atak BM, Duman TT,
Kahveci G, Khalid A and Aktas G: Does C-reactive protein to serum
albumin ratio correlate with diabEtic nephropathy in patients with
Type 2 dIabetes MEllitus? The CARE TIME study. Prim Care Diabetes.
15:1071–1074. 2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Jung SW, Kim DJ, Kim YG, Moon JY, Jeong KH
and Lee SH: Renal aging resembles a continuum between normal and
diseased kidneys that potentiates inflammatory response to injury.
J Gerontol A Biol Sci Med Sci. 76:385–392. 2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Kocak MZ, Aktas G, Duman TT, Atak BM,
Kurtkulagi O, Tekce H, Bilgin S and Alaca B: Monocyte lymphocyte
ratio as a predictor of diabetic kidney injury in type 2 diabetes
mellitus; The MADKID study. J Diabetes Metab Disord. 19:997–1002.
2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Musiał K and Zwolińska D: New markers of
cell migration and inflammation in children with chronic kidney
disease. Biomarkers. 24:295–302. 2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Kocak MZ, Aktas G, Atak BM, Duman TT, Yis
OM, Erkus E and Savli H: Is neuregulin-4 a predictive marker of
microvascular complications in type 2 diabetes mellitus? Eur J Clin
Invest. 50(e13206)2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Kin Tekce B, Tekce H, Aktas G and Sit M:
Evaluation of the urinary kidney injury molecule-1 levels in
patients with diabetic nephropathy. Clin Invest Med. 37:E377–E383.
2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Tekce H, Tekce BK, Aktas G, Alcelik A and
Sengul E: Serum omentin-1 levels in diabetic and nondiabetic
patients with chronic kidney disease. Exp Clin Endocrinol Diabetes.
122:451–456. 2014.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sakai K, Nozaki Y, Murao Y, Yano T, Ri J,
Niki K, Kinoshita K, Funauchi M and Matsumura I: Protective effect
and mechanism of IL-10 on renal ischemia-reperfusion injury. Lab
Invest. 99:671–683. 2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Black LM, Lever JM and Agarwal A: Renal
inflammation and fibrosis: A double-edged sword. J Histochem
Cytochem. 67:663–681. 2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tang PM, Nikolic-Paterson DJ and Lan HY:
Macrophages: Versatile players in renal inflammation and fibrosis.
Nat Rev Nephrol. 15:144–158. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Meng XM, Wang S, Huang XR, Yang C, Xiao J,
Zhang Y, To KF, Nikolic-Paterson DJ and Lan HY: Inflammatory
macrophages can transdifferentiate into myofibroblasts during renal
fibrosis. Cell Death Dis. 7(e2495)2016.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wei J, Xu Z and Yan X: The role of the
macrophage-to-myofibroblast transition in renal fibrosis. Front
Immunol. 13(934377)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Kang HM, Ahn SH, Choi P, Ko YA, Han SH,
Chinga F, Park AS, Tao J, Sharma K, Pullman J, et al: Defective
fatty acid oxidation in renal tubular epithelial cells has a key
role in kidney fibrosis development. Nat Med. 21:37–46.
2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Liu BC, Tang TT, Lv LL and Lan HY: Renal
tubule injury: A driving force toward chronic kidney disease.
Kidney Int. 93:568–579. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Wen Q, Liu J, Kang R, Zhou B and Tang D:
The release and activity of HMGB1 in ferroptosis. Biochem Biophys
Res Commun. 510:278–283. 2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Von Mässenhausen A, Tonnus W and
Linkermann A: Cell death pathways drive necroinflammation during
acute kidney injury. Nephron. 140:144–147. 2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Martin-Sanchez D, Ruiz-Andres O, Poveda J,
Carrasco S, Cannata-Ortiz P, Sanchez-Niño MD, Ruiz Ortega M, Egido
J, Linkermann A, Ortiz A and Sanz AB: Ferroptosis, but not
necroptosis, is important in nephrotoxic folic acid-induced AKI. J
Am Soc Nephrol. 28:218–229. 2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Shah R, Shchepinov MS and Pratt DA:
Resolving the role of lipoxygenases in the initiation and execution
of ferroptosis. ACS Cent Sci. 4:387–396. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Ha le M, Que do TN, Huyen do TT, Long PQ
and Dat NT: Toxicity, analgesic and anti-inflammatory activities of
tectorigenin. Immunopharmacol Immunotoxicol. 35:336–340.
2013.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Lee HU, Bae EA and Kim DH:
Hepatoprotective effect of tectoridin and tectorigenin on
tert-butyl hyperoxide-induced liver injury. J Pharmacol Sci.
97:541–544. 2005.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Pan CH, Kim ES, Jung SH, Nho CW and Lee
JK: Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory
responses in murine macrophage RAW 264.7 cells. Arch Pharm Res.
31:1447–1456. 2008.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Li J, Yang J, Zhu B, Fan J, Hu Q and Wang
L: Tectorigenin protects against unilateral ureteral obstruction by
inhibiting Smad3-mediated ferroptosis and fibrosis. Phytother Res.
36:475–487. 2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Xie J, Ye Z, Li L, Xia Y, Yuan R, Ruan Y
and Zhou X: Ferrostatin-1 alleviates oxalate-induced renal tubular
epithelial cell injury, fibrosis and calcium oxalate stone
formation by inhibiting ferroptosis. Mol Med Rep.
26(256)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Zhang B, Chen X, Ru F, Gan Y, Li B, Xia W,
Dai G, He Y and Chen Z: Liproxstatin-1 attenuates unilateral
ureteral obstruction-induced renal fibrosis by inhibiting renal
tubular epithelial cells ferroptosis. Cell Death Dis.
12(843)2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Luo Y, Chen H, Liu H, Jia W, Yan J, Ding
W, Zhang Y, Xiao Z and Zhu Z: Protective effects of ferroptosis
inhibition on high fat diet-induced liver and renal injury in mice.
Int J Clin Exp Pathol. 13:2041–2049. 2020.PubMed/NCBI
|
|
81
|
Yang L, Guo J, Yu N, Liu Y, Song H, Niu J
and Gu Y: Tocilizumab mimotope alleviates kidney injury and
fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model.
Life Sci. 261(118487)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Zhang Y, Jin D, Kang X, Zhou R, Sun Y,
Lian F and Tong X: Signaling pathways involved in diabetic renal
fibrosis. Front Cell Dev Biol. 9(696542)2021.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Wang Y, Bi R, Quan F, Cao Q, Lin Y, Yue C,
Cui X, Yang H, Gao X and Zhang D: Ferroptosis involves in renal
tubular cell death in diabetic nephropathy. Eur J Pharmacol.
888(173574)2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Zhou L, Xue X, Hou Q and Dai C: Targeting
ferroptosis attenuates interstitial inflammation and kidney
fibrosis. Kidney Dis (Basel). 8:57–71. 2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Zhang Z, Yao Z, Wang L, Ding H, Shao J,
Chen A, Zhang F and Zheng S: Activation of ferritinophagy is
required for the RNA-binding protein ELAVL1/HuR to regulate
ferroptosis in hepatic stellate cells. Autophagy. 14:2083–2103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Livingston MJ, Ding HF, Huang S, Hill JA,
Yin XM and Dong Z: Persistent activation of autophagy in kidney
tubular cells promotes renal interstitial fibrosis during
unilateral ureteral obstruction. Autophagy. 12:976–998.
2016.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Li W, Feng G, Gauthier JM, Lokshina I,
Higashikubo R, Evans S, Liu X, Hassan A, Tanaka S, Cicka M, et al:
Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil
recruitment after heart transplantation. J Clin Invest.
129:2293–2304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Masaldan S, Clatworthy SAS, Gamell C,
Meggyesy PM, Rigopoulos AT, Haupt S, Haupt Y, Denoyer D, Adlard PA,
Bush AI and Cater MA: Iron accumulation in senescent cells is
coupled with impaired ferritinophagy and inhibition of ferroptosis.
Redox Biol. 14:100–115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Wang J, Wang Y, Liu Y, Cai X, Huang X, Fu
W, Wang L, Qiu L, Li J and Sun L: Ferroptosis, a new target for
treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced
CKD rat model. Cell Death Discov. 8(127)2022.PubMed/NCBI View Article : Google Scholar
|
